{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:58:20Z","timestamp":1791107900209,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.euroneuro.2004.04.002","type":"journal-article","created":{"date-parts":[[2004,5,30]],"date-time":"2004-05-30T02:39:31Z","timestamp":1085884771000},"page":"23-30","source":"Crossref","is-referenced-by-count":63,"title":["Chlorpromazine and loxapine reduce interleukin-1\u03b2 and interleukin-2 release by rat mixed glial and microglial cell cultures"],"prefix":"10.1016","volume":"15","author":[{"given":"Krzysztof","family":"Labuzek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozena","family":"Gabryel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew S.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2004.04.002_BIB1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1471-4159.1993.tb13620.x","article-title":"Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells","volume":"61","author":"Alonso","year":"1993","journal-title":"J. Neurochem"},{"issue":"3\/4","key":"10.1016\/j.euroneuro.2004.04.002_BIB2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0736-5748(94)00072-B","article-title":"Differential effects of interleukin-13 and interleukin-2 on glia and hippocampal neurons in culture","volume":"13","author":"Araujo","year":"1995","journal-title":"Int. J. Dev. Neurosci"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB3","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.1992.263.1.C1","article-title":"Inflammatory cytokines within the central nervous system: sources, function and mechanism of action","volume":"263","author":"Benveniste","year":"1992","journal-title":"Am. J. Phsiol"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB4","first-page":"217","article-title":"Pharmacological activities of chlorpromazine involved in the inhibition of tumor necrosis factor production in vivo in mice","volume":"79","author":"Bertini","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/166.4.847","article-title":"Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone","volume":"166","author":"Chao","year":"1992","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00001756-199604260-00004","article-title":"Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage","volume":"7","author":"De Bock","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB7","series-title":"Cytokines and the CNS","first-page":"187","article-title":"Cytokines and defense against CNS infection","author":"Fontana","year":"1996"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.1830170909","article-title":"Antigen presentation and tumor cytotoxity by interferon-gamma-treated microglial cells","volume":"17","author":"Frei","year":"1987","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000112099","article-title":"The impact of microglia-derived cytokines upon gliosis in the CNS","volume":"16","author":"Giulian","year":"1994","journal-title":"Dev. Neurosci"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jnr.490210230","article-title":"Brain macrophages synthesize IL-1 and IL-1 mRNAs in vitro","volume":"21","author":"Hetier","year":"1988","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0197-0186(96)00086-1","article-title":"Protein tyrosine kinase inhibitors decrease lipopolisaccharide-induced proinflammatory cytokine production in mixed glia, microglia-enriched or astrocyte-enriched cultures","volume":"30","author":"Kong","year":"1997","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/15622970009150591","article-title":"In vitro immunomodulatory effects of haloperidol and perazine in schizophrenia","volume":"1","author":"Kowalski","year":"2000","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","article-title":"Neuroleptics normalize increased release of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 from monocytes in schizophrenia","volume":"50","author":"Kowalski","year":"2001","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","article-title":"Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine","volume":"89","author":"Maes","year":"1994","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(96)00029-1","article-title":"Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs","volume":"21","author":"Maes","year":"1996","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archpsyc.1989.01810100098019","article-title":"Effect of short term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients","volume":"46","author":"McAllister","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1176\/ajp.152.9.1291","article-title":"Increases in CSF levels of interleukin 2 in schizophrenia. Effects of recurrence of psychosis and medication status","volume":"152","author":"McAllister","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000111642","article-title":"Tumor necrosis factor alpha, interleukin-1 and related cytokines in brain development: normal and pathological","volume":"14","author":"Merill","year":"1992","journal-title":"Dev. Neurosci"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.58.9.585","article-title":"Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines","volume":"58","author":"Moots","year":"1999","journal-title":"Ann. Rheum. Dis"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0165-1781(91)90072-W","article-title":"Cellular immunity in schizophrenic patients before and during neuroleptic therapy","volume":"37","author":"M\u00fcller","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.1993.tb03331.x","article-title":"T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy","volume":"87","author":"M\u00fcller","year":"1993","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02922260","article-title":"Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia","volume":"247","author":"M\u00fcller","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(96)12460-5","article-title":"Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischaemia in gerbil brain","volume":"206","author":"Saito","year":"1996","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-3223(92)90085-E","article-title":"Drug distribution between blood and brain as a determinant of antipsychotic drug effects","volume":"32","author":"Tsuneizumi","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","article-title":"Drug and chemical blood-level data 2001","volume":"122","author":"Winek","year":"2001","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB26","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1097\/00001756-199712220-00003","article-title":"Microglial phagocytosis is modulated by pro-and anti-inflammatory cytokines","volume":"8","author":"Zahn","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.euroneuro.2004.04.002_BIB27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","article-title":"Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6","volume":"643","author":"Zalcman","year":"1994","journal-title":"Brain Res"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T16:56:19Z","timestamp":1549558579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X04000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0924977X04000574"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2004.04.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}